Mauritania vs Sudan: Treatment coverage for schistosomiasis
Mauritania
12.6%
in 2024
Sudan
35.1%
in 2022
Mauritania rank
40th
Sudan rank
37th
Treatment coverage for schistosomiasis over time
- Mauritania
- Sudan
How they compare
Sudan currently reports 35.1% against 12.6% in Mauritania, a difference of 22.5%.
That makes Sudan's figure about 2.8 times Mauritania's.
The two have swapped places 2 times across 8 shared years of data; in 2007 it was Sudan ahead.
Mauritania ranks 40th and Sudan ranks 37th of 45 countries.
Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritania | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6% | 4.4% | 3.8% | Sudan |
| 2010s | 24.3% | 29.5% | 5.3% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Mauritania or Sudan?
- Sudan, at 35.1% against 12.6% in Mauritania as of 2022.
- What is the difference in treatment coverage for schistosomiasis between Mauritania and Sudan?
- 22.5%, with Sudan ahead.
- How many years of comparable data are there for Mauritania and Sudan?
- 8 years are reported by both, from 2007 to 2019.
- How do Mauritania and Sudan rank globally for treatment coverage for schistosomiasis?
- Mauritania ranks 40th and Sudan ranks 37th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.